BIO International Convention 2025
Conference Name: BIO International Convention 2025
Time: June 16-19, 2025
Location: Boston, MA, USA
ARCALIS, Inc. and Axcelead Drug Discovery Partner, Inc., group companies of Axcelead, Inc., will be attending BIO International 2025 in Boston, MA, USA. Visit us at Booth #3278 to learn how we can empower your drug discovery. Let’s connect in the BIO Partnering™ system to discuss more details. Our team looks forward to meeting you there!
Satoshi Takamatsu, PhD
Corporate Officer, CDMO Business Supervisor, Axcelead, Inc. / Representative Director, President and CEO, ARCALIS, Inc.
- >30 years of experience in life sciences and CDMO business operation in companies such as Ajinomoto, Fujifilm, and AGC
- >50 cases of experience in M&A transactions in the life sciences and CDMO industries, with a total deal size of over 1 trillion yen
- >30 cases of experience in pharmaceutical licensing-in and licensing-out activities
- >15 publications, >20 patents in the field of pharmaceutical development and production
Yuki Hasegawa, PhD
Vice Chairperson, Business Development General Manager, ARCALIS, Inc./ Healthcare Investment Head, Whiz Partners, Inc
- >10 years of experience in genomic/transcriptome/stem cell research in Academia and experience in regenerative medicine business in Asahi Kasei
- >5 years of experience in business development
- >5 years of experience in investment and hands-on support in healthcare
- >20 publications in genomics and transcriptomics
Hamid Trimech
Business Development Manager, ARCALIS Inc
- Engineer, with a decade of experience in vaccine manufacturing and technology transfer
- Involved in the manufacturing projects on more than 15 different vaccines in France, South Korea, Japan, India, Brazil, Argentina and Mexico.
- 6 vaccines modalities, including attenuated, inactivated, subunit, recombinant protein, conjugated, and mRNA vaccines.
- Delivered 2 approved COVID-19 vaccines (protein / mRNA)
- Former Process Engineer at Sanofi Pasteur Global Engineering Department in charge of drug substance manufacturing projects in South America and Asia.
Yoshinori Ikeura, PhD
Board Director, Co-CEO and CTO, Axcelead, Inc. / Board Chairperson, Axcelead Drug Discovery Partners, Inc.
- Former Head of Shonan research center, Takeda Pharmaceutical Company
- Former Chairman of Japan Pharmaceutical Manufacturers Association R&D committee
- Former Board member of Japan Bio industry Association
- RSC, Med.Chem.Comm. editorial board
- >30 years of experience in drug discovery（>5 INDs)
- >15 publications, >15 patents
Masayuki Ii, PhD
CSO, Axcelead Drug Discovery Partners, Inc.
- Former Head of inflammation DDU, Takeda Pharmaceutical Company
- >25 years of experience in drug discovery and development, lead of research in global development programs
- >20 publications, >40 patents
Kazuyoshi Aso, PhD
Head, Global Business Development, Axcelead Drug Discovery Partners, Inc.
- Former VP, Head of Chemistry, Axcelead DDP
- Former VP, Head of Medicinal Chemistry, Tri-I TDI
- >5 years of experience in global business development
- >30 years of experience in drug discovery research
- >30 publications, >20 patents
Belinda Deng
Global Business Development, Axcelead Drug Discovery Partners, Inc.
- >10 years of experience in B2B marketing at global and Japanese companies, including Edwards, Stanley Black & Decker and Imada
- >5 years of experience in global sales and marketing
- 2 years of experience in global business development in the healthcare industry